[1] |
Rockey DC, Caldwell SH, Goodman ZD, et al. Liver Biopsy. Hepatology, 2009,49:1017-1044.
|
[2] |
张思敏,周海东,赵琳,等.不明原因肝功能异常患者的病因分析.肝脏,2014,19:31-33.
|
[3] |
高莉,章丽娜,何彩琴,等.232例自身免疫性肝病患者合并其他自身免疫病情况及预后分析.中华消化杂志,2015,35:90-94.
|
[4] |
Lucena MI, Andrade RJ, Kaplowitz N, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology, 2009,49:2000-2009.
|
[5] |
Wehling M. Non-steroidal anti-inflammatory drug use in chronic pain conditions with special emphasis on the elderly and patients with relevant comorbidities: management and mitigation of risks and adverse effects. Eur J Clin Pharmacol, 2014,70:1159-1172.
|
[6] |
刘丽娜,赵建学,陆玮婷,等.138例药物性肝损伤患者影响预后的因素分析.实用肝脏病杂志,2015,18:160-163.
|
[7] |
姚云洁,刘鸿凌,朱冰,等.441 例药物性肝损伤患者临床和肝组织病理学特征分析.实用肝脏病杂志,2015,18:286-289.
|
[8] |
Farrell GC, Larter CZ. Nonalcoholic fatty liver disease:from steatosis to cirrhosis. Hepatology, 2006,43:S99-S112.
|